Corynebacterium Diphtheriae

Diphtheria, caused by Corynebacterium diphtheriae, is a classic example of a bacterial disease where the primary damage is inflicted not by the bacterium itself, but by a potent exotoxin it produces. While immunization has made it rare in many parts of the world, understanding this pathogen remains crucial for medical professionals. It integrates foundational microbiology, molecular pathogenesis, and clinical medicine, making it a high-yield topic for exams like the MCAT and essential knowledge for any pre-medical or medical student.

Bacteriology and Pathogenesis

Corynebacterium diphtheriae is a gram-positive, club-shaped rod that is non-motile and non-spore-forming. A key identifying feature under microscopic examination is the presence of metachromatic granules, also called volutin granules, which are storage deposits of polyphosphate that stain intensely with certain dyes like methylene blue. The bacteria are typically arranged in palisades or in V-shaped patterns, resembling Chinese letters.

The critical twist in its pathogenicity is that not all strains of C. diphtheriae cause disease. The virulent, toxin-producing strains are those infected by a specific virus—a beta-prophage (a bacteriophage integrated into the bacterial chromosome). This lysogenic phage carries the tox gene, which encodes the diphtheria exotoxin. Therefore, the bacterium must be lysogenized by this phage to become pathogenic. This is a prime example of lysogenic conversion, where a bacterium acquires new pathogenic properties from a phage.

Mechanism of the Diphtheria Toxin

The diphtheria exotoxin is the master key to the disease's severity. It is an A-B type exotoxin, meaning it has two functional subunits. The B (binding) subunit attaches to specific heparin-binding epidermal growth factor (HB-EGF) receptors on the surface of many human cells, particularly heart and nerve cells. Following receptor-mediated endocytosis, the toxin enters the cell.

Inside the endosome, the A (active) subunit is released and translocates into the cytoplasm. Here, it performs its destructive action: it catalyzes the ADP-ribosylation of elongation factor 2 (EF-2). EF-2 is an essential protein required for translocating the growing polypeptide chain on the ribosome during protein synthesis. By transferring an ADP-ribose group onto a modified histidine residue (diphthamide) on EF-2, the toxin inactivates EF-2. This irreversible modification halts cellular protein synthesis, leading to cell death. A single molecule of the A fragment can ADP-ribosylate enough EF-2 to kill a cell, demonstrating its extraordinary potency.

Clinical Presentation and Complications

The local effects of the bacteria and toxin manifest in the respiratory form of the disease. C. diphtheriae colonizes the mucosa of the pharynx and tonsils, causing necrosis of the epithelial cells. The combination of necrotic tissue, fibrin, white blood cells, and bacteria forms a tough, adherent, grayish pseudomembrane. This membrane can extend and is a hallmark of the disease; attempting to remove it often causes bleeding.

Systemically, the exotoxin is absorbed into the bloodstream and distributed, causing damage to distant organs. Locally, severe edema and lymphadenopathy can lead to the characteristic "bull-neck" appearance due to massive swelling of the cervical lymph nodes.

The two most serious systemic complications are myocarditis and neuropathy. Myocarditis typically occurs 1-2 weeks after onset and is a direct result of toxin-mediated inhibition of protein synthesis in cardiac muscle cells, leading to heart failure and arrhythmias. Neuropathy often presents later (3-7 weeks) as a descending motor paralysis, beginning with palatal and pharyngeal weakness (leading to a nasal voice and difficulty swallowing), and can progress to involve ocular muscles, the diaphragm, and limbs.

Prevention: Vaccination

The cornerstone of diphtheria control is active immunization with the DPT vaccine (more accurately, the DTaP or Tdap vaccines in current use). The "D" stands for diphtheria toxoid. A toxoid is an inactivated toxin that retains its immunogenicity but loses its toxicity. The vaccine contains purified diphtheria toxin that has been treated with formaldehyde, converting it into a harmless toxoid.

When administered, the toxoid stimulates the production of neutralizing antibodies (antitoxin). If a vaccinated individual is later exposed to the actual diphtheria toxin, these pre-formed antibodies bind to the toxin and prevent it from attaching to and entering cells, thereby providing protection. Vaccination is part of the routine childhood schedule (DTaP) and is recommended for booster in adolescents and adults (Tdap) to maintain immunity. Widespread vaccination creates herd immunity, protecting those who cannot be vaccinated.

Common Pitfalls

1. Confusing the source of the toxin gene. A common mistake is to believe the toxin is encoded on a plasmid. Remember: the gene for diphtheria toxin (tox) is carried by a beta-prophage. Lysogenic conversion is the key concept here.
2. Misunderstanding the toxin's target. It's easy to confuse molecular targets. The toxin does not affect DNA synthesis or directly damage cell membranes. Its precise action is the ADP-ribosylation of elongation factor 2 (EF-2), which halts protein synthesis.
3. Focusing only on the pharyngitis. While the pseudomembrane is iconic, the life-threatening aspects of diphtheria are its systemic complications. Always associate diphtheria with potential myocarditis and neuropathy.
4. Overlooking the role of vaccination in treatment. Antitoxin (horse serum-derived antibodies) is the urgent, specific treatment to neutralize circulating toxin. However, antibiotics like penicillin or erythromycin are also given—not primarily to treat the systemic disease, but to eradicate the carrier state and stop further toxin production. Vaccination is for prevention, not acute treatment.

Summary

• Corynebacterium diphtheriae is a gram-positive, club-shaped rod with metachromatic granules. Its pathogenicity depends on lysogenic conversion by a beta-prophage carrying the toxin gene.
• The diphtheria exotoxin is an A-B toxin that enters cells and causes irreversible ADP-ribosylation of elongation factor 2 (EF-2), halting protein synthesis and leading to cell death.
• Clinically, it causes a pseudomembranous pharyngitis with a characteristic adherent gray membrane. Local swelling can cause "bull-neck" lymphadenopathy.
• The absorbed toxin causes severe systemic effects, most notably myocarditis (heart muscle inflammation) and neuropathy (descending paralysis).
• Prevention is achieved through the DPT/DTaP/Tdap vaccine, which contains diphtheria toxoid to induce protective antitoxin antibodies, highlighting one of the great successes of public health immunization programs.